Co-ordinated changes in expression of cell adhesion molecules in prostate cancer

European Journal of Cancer Part A

Volumn 33, Issue 2, 1997, Pages 263-271

  Murant, S J ^a   Handley, J ^a   Stower, M ^b   Reid, N ^b   Cussenot, O ^c   Maitland, N J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Adhesion molecules; Cadherin; Catenin; CD44; Integrin; Prostate cancer

Indexed keywords

CADHERIN; CATENIN; CELL ADHESION MOLECULE; HERMES ANTIGEN; INTEGRIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

EID: 0030888322     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00418-2     Document Type: Article

References (35)

1. Isaacs WB, Carter BS. Genetic changes associated with prostate cancer in humans. Cancer Surveys: Prostate Cancer 1991, 11, 15-24.
2. Visakorpi T, Kallioniemi AH, Syvänen A-C, et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995, 55, 342-347.
3. Hedrick L, Cho KR, Vogelstein B. Cell adhesion molecules as tumour suppressors. TICB 1993, 3, 36-39.
4. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993, 5, 806-811.
5. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992, 52, 5104-5109.
6. Carter BS, Ewing CM, Ward WS, et al. Allelic losses of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990, 87, 8751-8755.
7. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989, 8, 1711-1717.
8. Shimoyama Y, Nagafuchi A, Fujita S, et al. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992, 52, 5770-5774.
9. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 1993, 53, 3585-3590.
10. Pignatelli M, Vessey J. Adhesion molecules: novel molecular tools in tumour pathology. Prog Pathol 1994, 25, 849-856.
11. Tang DG, Honn KV. Adhesion molecules and tumour metastasis: an update. Invasion Metastasis 1994-5, 14, 109-122.
12. 6-integrins in the normal and neoplastic prostate. Am J Pathol 1994, 145, 167-174.
13. 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular liglands. Hum Pathol 1993, 24, 243-248.
14. Nagle RB, Hao J, Knox JD, et al. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 1995, 146, 1498-1507.
15. Nagle RB, Knox JD, Wolf C, Bowden GT, Cress AE. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem 1994, 19, 232-237.
16. 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin Exp Met 1993, 11, 391-400.
17. Witkowski CM, Rabinovitz I, Nagle RB, Affinito K-SD, Cress AE. Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. J Cancer Res Clin Oncol 1993, 119, 637-644.
18. Rokhlin OW, Cohen MB. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate 1995, 26, 205-212.
19. Günthert U, Stauder R, Mayer B, Terpe H-J, Finke L, Friedrichs K. Are CD44 variant isoforms involved in human tumour progression. Cancer Surv 1995, 24, 19-42.
20. Liu AY. Expression of CD44 in prostate cancer cells. Cancer Lett 1994, 76, 63-69.
21. Lokeshwar BL, Lokeshwar VB, Block NL. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential. Anticancer Res 1995, 15, 1191-1198.
22. Stevens JW, Palechek PL, Greibling TL, et al. Expression of CD44 isoforms in human prostate tumour cell lines. The Prostate 1996, 28, 153-161.
23. Doorbar J, Ely S, Sterling J, et al. Specific interaction between HPV16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament nework. Nature 1991, 352, 824-827.
24. Gleason D. Classification of prostatic carcinomas. Cancer Chemother Rev 1966, 50, 125.
25. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994, 54, 3929-3933.
26. Washington K, Gottfried MR, Telen MJ. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 1994, 25, 1043-1049.
27. Ichikawa T, Ichikawa Y, Dong J, et al. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 1992, 52, 3486-3490.
28. Dong J-T, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268, 884-886.
29. Hodivala KJ, Watt FM. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. JCB 1994, 124, 589-600.
30. MacCalman CD, Brodt P, Doublet JD, et al. The loss of E-cadherin mRNA transcripts in rat prostatic tumors is accompanied by increased expression of mRNA transcripts encoding fibronectin and its receptor. Clin Exp Met 1994, 12, 101-107.
31. Okada H, Tsubura A, Okamura A, et al. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch Am Pathol Anat Hispathol 1992, 421, 157-161.
32. Abrahamsson P-A, di Sant' Agnese PA. Neuroendocrine cells in the human prostate gland. J Androl 1993, 14, 307-309.
33. Aprikian AG, Cordon-Cordo C, Fair WR, Reuter VE. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993, 71, 3952-3965.
34. Anderson M, Handley J, Hopwood L, Murant S, Stower M, Maitland NJ. Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning and automated sequencing. J Med Virol, in press.
35. Cuzick J. Human papilloma infection of the prostate. Cancer Surveys: Preventing Prostate Cancer: Screening Versus Chemoprevention 1995, 23, 91-95.